Microdosing for stroke recovery

Psychedelic Pharmaceutical Startup Ninnion Announces Patent Filings and Development of NIN-S119 for Ischemic Stroke

Ninnion Therapeutics, a private Texas-based company, hopes microdosing will help patients recover from strokes.

Ischemic strokes block blood flow to the brain, causing brain cells to die. 

Microdosing in combination with occupational therapy may be able to strengthen the remaining brain cells to restore lost functions.

The company recently filed a patent application for the treatment. Since there are no approved drugs for stroke recovery, the formulation may qualify for a Breakthrough Therapy designation, which would speed up the development timeline. 

PDF of article